In a 40-patient randomized trial, moderate hypothermia (28-32°C) during heart bypass surgery lowered a marker of brain cell injury (S100β) compared to milder cooling (32-34°C), though this finding needs validation in larger studies.
Neurological complications remain a significant concern in cardiac surgery despite improvements in surgical technique and anesthesia. When surgeons use cardiopulmonary bypass (CPB)—a machine that temporarily takes over heart and lung function—the body experiences stress that can trigger brain cell injury. Hypothermia, or deliberate cooling, is already standard practice during these procedures because lower body temperature reduces metabolic demand and theoretically protects the brain. What wasn't clear: how cold is cold enough, and at what point does cooling stop helping?
This single-center randomized controlled trial enrolled 40 patients undergoing coronary artery bypass grafting (CABG) and assigned them to either mild hypothermia (32-34°C) or moderate hypothermia (28-32°C) during bypass. The researchers measured two serum biomarkers of brain injury: neuron-specific enolase (NSE), which leaks from damaged neurons, and S100β, a protein released by brain cells under stress. They also monitored cerebral oxygen levels using near-infrared spectroscopy (NIRS) and assessed cognitive function with the Mini-Mental State Examination (MMSE) at multiple timepoints through 48 hours post-surgery.
The results showed that NSE levels rose in both groups after surgery with no significant difference between them. However, S100β levels were notably lower in the moderate hypothermia group at both 24 hours (p = 0.012) and 48 hours (p = 0.004) post-operatively. This suggests that deeper cooling may have reduced the amount of brain cell stress or injury. Importantly, cerebral oxygenation measured by NIRS remained comparable between groups, and cognitive scores on the MMSE were similar at follow-up. The authors interpreted this pattern as evidence that moderate hypothermia provided additional neuroprotection without compromising blood oxygen delivery to the brain or cognitive outcomes.
The distinction matters because it challenges assumptions about an optimal "one-size-fits-all" cooling depth. If moderate hypothermia truly attenuates brain injury markers without downsides, it could become a refined standard during high-risk cardiac procedures. However, the authors themselves note the limitation: this is a small, single-center study with only 40 patients and only one primary outcome measure. The MMSE is also a blunt cognitive screening tool and may miss subtle post-operative cognitive dysfunction that longer or more sensitive testing might detect.
This study is relevant primarily to cardiac surgeons and anesthesiologists managing patients undergoing CPB surgery, not to the general population. If you or a family member faces cardiac bypass surgery, this research adds a modest evidence base for asking your surgical team about their hypothermia protocols during the procedure. The finding that moderate cooling reduces a specific brain injury marker without obvious harm is encouraging, but it remains preliminary.
The broader takeaway is that temperature management during surgery—a controllable variable—may offer neuroprotection. That said, this single trial does not yet justify changing clinical practice. Larger, multi-center studies would be needed to confirm whether moderate hypothermia reduces long-term neurological complications (like post-operative cognitive decline or stroke), which are the clinically meaningful endpoints that patients actually care about.
For individuals concerned about brain health during surgical procedures, the conversation with your surgical team should focus on their overall approach to preventing neurological injury during bypass: this includes not only temperature management but also perfusion strategy, blood pressure targets, and protocols for managing air emboli.
| Aspect | Details |
|---|---|
| Study Type | Randomized controlled trial |
| Sample Size | 40 patients (n = 20 per group) |
| Setting | Single center |
| Intervention | Mild hypothermia (32-34°C) vs moderate hypothermia (28-32°C) during CPB |
| Primary Outcome | Between-group difference in S100β at 24 and 48 hours |
| Secondary Outcomes | NSE levels, NIRS cerebral oxygenation, MMSE cognitive scores |
| Key Finding | S100β significantly lower in moderate hypothermia group (p = 0.012 at 24h, p = 0.004 at 48h); no significant differences in NSE, oxygenation, or cognition |
| Limitations | Small sample size, single center, short follow-up period, limited cognitive testing, only biomarkers (not clinical outcomes) |
| Journal | Cardiovascular Journal of Africa |
| Year | 2024 |
Pubmed: https://pubmed.ncbi.nlm.nih.gov/42345556/
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.